Ladislav vystudoval Přírodovědeckou Fakultu UK a má dlouholeté zkušenosti z výzkumu v ČR, USA a Německu. Je zakladatelem několika úspěšných biotechnologických společností u nás a ve Švýcarsku.
Laboratory of Immunology, Research Institute of Endocrinology, Prague, Czech Republic |
1989 – 1991 |
Institute of Biochemistry and Medical chemistry, University of Bari, Bari, Italy |
1993 |
Institute of Physiology, ASCR, Prague, Czech Republic |
1991 – 1997 |
Johns Hopkins University, Oncology Center, Baltimore, Maryland, USA, postdoctoral stay |
1997 – 2000 |
Department of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital of Ulm, Ulm, Germany, postdoctoral stay, habilitation |
2000 – 2005 |
GEN-TREND s.r.o., Czech Republic, Research & Development Director |
2005 – 2008 |
Hutman Diagnostics AG, Switzerland, Chief Scientific Officer |
2011 – 2012 |
Protean s.r.o., Czech Republic, Research & Development Director, Ceo |
2008 – present |
Grant Agency of the Czech Republic: Regulation of expression and function of pyrogenic cytokines in somatic cells. |
1995 – 1997 |
National Institute of Health, USA: Cloning and characterization of novel Kaposi’s sarcoma herpes virus-encoded interferon regulatory factors. |
1997 – 2000 |
University of Ulm, Germany: Cloning and characterization of human homologue of viral interferon regulatory factor 2 (vIRF-2). |
2001 – 2003 |
Deutsches Forschunggesellschaft (DFG), Germany: Characterization of virus-induced transcription factors and regulation of gene expression of the host cell. |
2002 – 2004 |
Ministry of Industry and Trade of the Czech Republic, Project Impulse: Development and manufacture of new generation of molecular biological diagnostic kits for parallel "macroarray" detection of human pathogens. |
2004 – 2006 |
German-Israeli Project Cooperation (DIP), The German Ministry for Education and Research (BMBF), Germany: The role of intracellular IL-1 alpha in health and disease: mechanisms of action and therapeutic applications. |
2005 |